Exploring drug combinations in genetic interaction network

BackgroundDrug combination that consists of distinctive agents is an attractive strategy to combat complex diseases and has been widely used clinically with improved therapeutic effects. However, the identification of efficacious drug combinations remains a non-trivial and challenging task due to the huge number of possible combinations among the candidate drugs. As an important factor, the molecular context in which drugs exert their functions can provide crucial insights into the mechanism underlying drug combinations.ResultsIn this work, we present a network biology approach to investigate drug combinations and their target proteins in the context of genetic interaction networks and the related human pathways, in order to better understand the underlying rules of effective drug combinations. Our results indicate that combinatorial drugs tend to have a smaller effect radius in the genetic interaction networks, which is an important parameter to describe the therapeutic effect of a drug combination from the network perspective. We also find that drug combinations are more likely to modulate functionally related pathways.ConclusionsThis study confirms that the molecular networks where drug combinations exert their functions can indeed provide important insights into the underlying rules of effective drug combinations. We hope that our findings can help shortcut the expedition of the future discovery of novel drug combinations.

[1]  Xin Chen,et al.  DCDB: Drug combination database , 2010, Bioinform..

[2]  Xing-Ming Zhao,et al.  Exploring drug combinations in a drug-cocktail network , 2011, 2011 IEEE International Conference on Systems Biology (ISB).

[3]  Athanassios Argiris,et al.  Synergistic Interactions between Tamoxifen and Trastuzumab (Herceptin) , 2004, Clinical Cancer Research.

[4]  Xing-Ming Zhao,et al.  A systems biology approach to identify effective cocktail drugs , 2010, BMC Systems Biology.

[5]  BMC Bioinformatics , 2005 .

[6]  Rachel Schiff,et al.  Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer. , 2003, Breast.

[7]  Xiaobo Zhou,et al.  An enhanced Petri-net model to predict synergistic effects of pairwise drug combinations from gene microarray data , 2011, Bioinform..

[8]  N. Kerrouche,et al.  A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0·01%, hydroquinone 4%, tretinoin 0·05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma , 2008, The British journal of dermatology.

[9]  N. Curtin,et al.  Potentiation of paclitaxel-induced apoptosis by the novel cyclin-dependent kinase inhibitor NU6140: a possible role for survivin down-regulation , 2005, Molecular Cancer Therapeutics.

[10]  Susan E. Abbatiello,et al.  Erratum: Synergistic drug combinations tend to improve therapeutically relevant selectivity , 2009, Nature Biotechnology.

[11]  Jacob D. Feala,et al.  Search Algorithms as a Framework for the Optimization of Drug Combinations , 2008, PLoS Comput. Biol..

[12]  Ann-Shyn Chiang,et al.  Identification of combinatorial drug regimens for treatment of Huntington's disease using Drosophila. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[13]  P. Bork,et al.  Drug Target Identification Using Side-Effect Similarity , 2008, Science.

[14]  Luhua Lai,et al.  Prediction of potential drug targets based on simple sequence properties , 2007, BMC Bioinformatics.

[15]  Desmond J. Smith,et al.  A genome-wide map of human genetic interactions inferred from radiation hybrid genotypes. , 2010, Genome research.

[16]  J. Bertino,et al.  The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  Bo Zhang,et al.  Network target for screening synergistic drug combinations with application to traditional Chinese medicine , 2011, BMC Systems Biology.

[18]  Xing-Ming Zhao,et al.  Automatic Modeling of Signaling Pathways by Network Flow Model , 2009, J. Bioinform. Comput. Biol..

[19]  H. Cordell Detecting gene–gene interactions that underlie human diseases , 2009, Nature Reviews Genetics.

[20]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[21]  Xing-Ming Zhao,et al.  Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data , 2011, PLoS Comput. Biol..

[22]  K. Aihara,et al.  Uncovering signal transduction networks from high-throughput data by integer linear programming , 2008, Nucleic acids research.

[23]  Michael Costanzo,et al.  Systematic exploration of synergistic drug pairs , 2011, Molecular systems biology.

[24]  P M Nair,et al.  Organophosphate poisoning in children - atropine, pralidoxime or both? , 2001, Saudi medical journal.

[25]  U. Alon,et al.  Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-Drug Responses , 2010, Cell.

[26]  S. Crow,et al.  Pharmacokinetic interactions between cyclosporine and bupropion or methylphenidate. , 2001, Journal of child and adolescent psychopharmacology.

[27]  Susumu Goto,et al.  KEGG for representation and analysis of molecular networks involving diseases and drugs , 2009, Nucleic Acids Res..